Osium AI (YC S23)’s Post

The insights presented in the 2023 European Deep Tech Report by Lakestar, Walden Catalyst Ventures and Dealroom.co are - once again - invaluable. Spotlight on a few key findings:   🚀 Deep Tech is firmly the #1 VC funding category in Europe. 🔎 10 key technologies have been identified by the European Union as crucial to preserve EU sovereignty, aiming at reducing dependence on external reliance. 🌍 Mega-waves of progress are expected to result from the advancements in these technologies, giving rise to numerous large-scale companies. With a strategic focus on Deep Tech in Space Tech, AI, Future of Compute, Novel Energy e Computational Biology, Obloo Ventures' investment strategy fully aligns with these insights. We are confident that these breakthrough innovations will play a pivotal role in positioning Europe as a global hub for Deep Tech excellence. Full report available at link in the first comment👇🏼  #EuropeanVC #DeepTech #EuropeanInnovation #deepscover #obloo

Our portfolio company Activeloop announced $11M Series A funding from investors like Streamlined Ventures, Y Combinator, Samsung Next, Alumni Ventures, and Dispersion Capital. Congrats Davit Buniatyan and team! Activeloop Deep Lake's enterprise readiness is proven by running in production with several Fortune 500 companies and innovative organizations like Bayer Radiology, Matterport, and others. Deep Lake is the Database for AI. It addresses the crucial need for a unified, efficient approach to handle the vast, untapped reserves of complex, unstructured data and bridges the gap between AI model training and production. Check out the news here: https://lnkd.in/dAN-f6ca

The AI sector in Miami is undergoing a significant expansion, featuring a diverse array of 812 organizations, with 720 companies leading the charge. The industry is particularly robust in the Biomed field, with 220 companies, and is well-supported by 170 financial institutions focusing on AI applications. A cohort of 85 investors is propelling the industry forward, with 45 venture capital firms at the forefront, indicating a strong inclination towards nurturing innovation. Additionally, Miami boasts 7 AI hubs, including 5 accelerators, which serve as the backbone for fostering growth and providing resources to burgeoning AI ventures. For a detailed understanding of Miami’s AI ecosystem and to engage with its key components, visit https://lnkd.in/eU-c6RGT Our strategic partner Ecosystem Mapping-as-a-Service remains open for inquiries on commissioned ecosystem map platforms in other industries and regions, some done on a pro-bono co-branded basis, and can be reached for inquiries here: https://lnkd.in/eHBp-8x8 #MiamiAI #Biomed #VentureCapital #InnovationHubs #AITechnology

We are thrilled to introduce our latest venture: SofinnovaAI. This innovative artificial intelligence platform is set to redefine our approach to life sciences investments, marking a new era in our firm's 50-year history. SofinnovaAI represents the culmination of our commitment to blending cutting-edge technology with deep industry expertise. Our dedicated team of data scientists and AI experts crafted SofinnovaAI to integrate advanced computational capabilities with our expansive proprietary data. It is this combination that sets it apart - and enables us to gain extraordinary insights into the life sciences sector, enhancing our deal origination and portfolio growth through data-driven insights. The platform is equipped to analyze the global corpus of scientific knowledge in real-time, including over 90 million authors, 40 million publications, and vast arrays of patents and clinical trials. It transcends the conventional methods of investment sourcing, tapping into billions of data points across scientific literature and emerging therapeutic fields. This approach allows us to identify and pursue 'moonshots' with an unprecedented level of speed and precision. We believe this platform will enable us to quickly identify the best investment opportunities, letting us focus more on leveraging our collective human intelligence to build robust entrepreneurial relationships. This is a significant step forward in our mission to partner with innovators shaping the future of life sciences. Read more: https://hubs.ly/Q02bYzRx0 Antoine Papiernik Anta (Ada) Gkelou Javier Nunez-Vicandi Marie Duranteau Enzo Petrelluzzi Stéphanie HUIBAN #Innovation #VentureCapital #investment #SofinnovaAI

You've probably already spotted... it's London Tech Week!  The largest festival of UK tech to date, with 25,000 people expected at Olympia this week, getting up to 45,000 across the entire fringe. This year we’re highlighting the truly impressive growth in the UK's AI and critical technology sectors, demonstrating the UK’s position as a global tech superpower. As part of this, Tech Nation launched its annual report, which found the UK AI sector reached a combined market valuation of $92bn in Q1 2024. The UK has secured its position as number one in Europe for AI investment – now home to 1,800 VC-backed AI startups and 20 AI unicorns. Check out Founders Forum Group & Tech Nation CEO Carolyn Dawson on Bloomberg this morning: https://lnkd.in/eUB9rixj And read the report here: https://lnkd.in/eXPZzKNF Francesca Arese Lucini Emily Miller Marco De Novellis Imogen Granger Ellie Steel Brent Hoberman

BrainScan.AI as one of the Top Disruptors in Healthcare since 2020! Every year, thanks to Koalicja AI i innowacji w zdrowiu, Ligia Kornowska, MD, and Karolina Kornowska, we have the pleasure of being included in the Top Disruptors in Healthcare Report, which provides a comprehensive landscape of innovations in the medical sector. The main goal of the report is to help startups establish partnerships with investors, medical entity partners, and end customers. This year's edition is distinguished by in-depth statistical research, taking into account factors such as the needs of the startups, information about their solutions, challenges, and financing. You can find the English version of the report here: https://lnkd.in/d8hg3hUG

This marks the beginning of a new chapter is how accounting firms will operate by leveraging AI in their daily work. #askMarcum

Thoughtful use and Good Integrity will help streamline the current Workloads

The launch of our AskMarcum.ai tool is a perfect example on how Marcum LLP is a trail blazer in Generative AI. To echo Peter J Scavuzzo's post - this is just the start and stay tuned! To learn more, visit: http://www.askmarcum.ai/ #askmarcum #AI #generativeAI

🚀 We are aiming for the moon as we launch #SofinnovaAI, a bespoke artificial intelligence platform that is set to transform our life sciences investment practice, bringing a new dimension to our analytical capabilities. Did you know that there is a new paper published every two minutes in the scientific world? That means staying abreast of the latest research is a colossal task. SofinnovaAI is now here to help ensure we remain at the forefront of life sciences innovation. What sets SofinnovaAI apart is not just its cutting-edge technology, but the depth of our proprietary data. It combines real-time scientific databases with our extensive, hand-analyzed data, accumulated over 50 years. This unique asset enables us to identify life science 'moonshots' with incredible speed and precision, a significant leap from conventional methods. The investment world is going through a new stage in its digital transformation, and SofinnovaAI, developed stealthily over four years, is emblematic of this. Our platform is not a response to the AI buzz but a strategic move to harness the acceleration of scientific innovation, leveraging our rich data to discover and invest in transformative life science ventures. SofinnovaAI represents the fusion of our longstanding data-driven approach and our commitment to innovation. It's a testament to our continuous evolution, the motor that drives us to find groundbreaking therapies and entrepreneurial talent in life sciences. Read more: https://hubs.ly/Q02cb4Fl0 Antoine Papiernik, Anta (Ada) Gkelou, Javier Nunez-Vicandi, Enzo Petrelluzzi, Marie Duranteau, Stéphanie HUIBAN #Innovation #SofinnovaAI #LifeSciences #VentureCapital